Skip to main content
PMC home page
The Journal of Experimental Medicine logoLink to The Journal of Experimental Medicine
. 1972 Nov 30;136(6):1631–1647. doi: 10.1084/jem.136.6.1631

DEPRESSED CELL-MEDIATED IMMUNITY IN PATIENTS WITH PRIMARY INTRACRANIAL TUMORS

CHARACTERIZATION OF A HUMORAL IMMUNOSUPPRESSIVE FACTOR

William H Brooks 1, Martin G Netsky 1, David E Normansell 1, David A Horwitz 1
PMCID: PMC2139329  PMID: 4345108

Abstract

Tumor immunity in patients with primary intracranial tumors was assessed in relation to the general status of host immunocompetence. Lymphocyte sensitization to tumor-specific membrane antigens was demonstrated by the proliferative response of lymphocytes in the presence of autochthonous tumor cells. Paradoxically, one-half of the patients could not be sensitized to a primary antigen, dinitrochlorobenzene; existing delayed hypersensitivity was also depressed, as measured by skin tests and lymphocyte transformation in response to common antigens. A heat-stable factor in patients' sera blocked cell-mediated tumor immunity. In addition, these "enhancing" sera consistently suppressed the blastogenic response of autologous and homologous lymphocytes to phytohemagglutinin and to membrane antigens on allogeneic cells in the one-way mixed lymphocyte culture. When patients' leukocytes were washed and autologous plasma replaced with normal plasma, reactivity in the mixed lymphocyte culture increased to normal values. In vitro immunosuppressive activity in patients' plasma or sera correlated with depressed delayed hypersensitivity. After removal of the tumor, suppressor activity disappeared. IgG fractions of patient sera contained strong immunosuppressive activity. These data suggest that the suppressor factor may be an isoantibody elicited by the tumor that also binds to receptors on the lymphocyte membrane. In addition to specifically blocking cell-mediated tumor immunity, enhancing sera may broadly depress host immunocompetence.

Full Text

The Full Text of this article is available as a PDF (836.9 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bach F. H., Voynow N. K. One-way stimulation in mixed leukocyte cultures. Science. 1966 Jul 29;153(3735):545–547. doi: 10.1126/science.153.3735.545. [DOI] [PubMed] [Google Scholar]
  2. Benjamin D. C., Weigle W. O. The termination of immunological unresponsiveness to bovine serum albumin in rabbits. I. Quantitative and qualitative response to cross-reacting albumins. J Exp Med. 1970 Jul 1;132(1):66–76. doi: 10.1084/jem.132.1.66. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Blaese R. M., Oppenheim J. J., Seeger R. C., Waldmann T. A. Lymphocyte-macrophage interaction in antigen induced in vitro lymphocyte transformation in patients with the Wiskott-Aldrich syndrome and other diseases with anergy. Cell Immunol. 1972 Jul;4(3):228–242. doi: 10.1016/0008-8749(72)90027-5. [DOI] [PubMed] [Google Scholar]
  4. Brunschwig A., Southam C. M., Levin A. G. Host resistance to cancer. Clinical experiments by homotransplants, autotransplants and admixture of autologous leucocytes. Ann Surg. 1965 Sep;162(3):416–425. doi: 10.1097/00000658-196509000-00011. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Bubeník J., Perlmann P., Helmstein K., Moberger G. Cellular and humoral immune responses to human urinary bladder carcinomas. Int J Cancer. 1970 May 15;5(3):310–319. doi: 10.1002/ijc.2910050303. [DOI] [PubMed] [Google Scholar]
  6. Catalona W. J., Taylor P. T., Rabson A. S., Chretien P. B. A method for dinitrochlorobenzene contact sensitization. A clinicopathological study. N Engl J Med. 1972 Feb 24;286(8):399–402. doi: 10.1056/NEJM197202242860804. [DOI] [PubMed] [Google Scholar]
  7. Ceppellini R., Bonnard G. D., Coppo F., Miggiano V. C., Pospisil M., Curtoni E. S., Pellegrino M. Transplantation antigens: introductory symposium. Mixed leukocyte cultures and HL-A antigens. I. Reactivity of young fetuses, newborns and mothers at delivery. Transplant Proc. 1971 Mar;3(1):58–63. [PubMed] [Google Scholar]
  8. Cooperband S. R., Bondevik H., Schmid K., Mannick J. A. Transformation of human lymphocytes: inhibition by homologous alpha globulin. Science. 1968 Mar 15;159(3820):1243–1244. doi: 10.1126/science.159.3820.1243. [DOI] [PubMed] [Google Scholar]
  9. Eilber F. R., Morton D. L. Impaired immunologic reactivity and recurrence following cancer surgery. Cancer. 1970 Feb;25(2):362–367. doi: 10.1002/1097-0142(197002)25:2<362::aid-cncr2820250213>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  10. Feldmann M., Diener E. Antibody-mediated suppression of the immune response in vitro. I. Evidence for a central effect. J Exp Med. 1970 Feb;131(2):247–274. doi: 10.1084/jem.131.2.247. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Golub E. S. Brain-associated theta antigen: reactivity of rabbit anti-mouse brain with mouse lymphoid cells. Cell Immunol. 1971 Aug;2(4):353–361. doi: 10.1016/0008-8749(71)90070-0. [DOI] [PubMed] [Google Scholar]
  12. Greaves M. F., Torrigiani G., Roitt I. M. Inhibition of human mixed lymphocyte reaction by antibodies to immunoglobulin light chain determinants. Clin Exp Immunol. 1971 Sep;9(3):313–328. [PMC free article] [PubMed] [Google Scholar]
  13. Hellström I., Hellström K. E., Bill A. H., Pierce G. E., Yang J. P. Studies on cellular immunity to human neuroblastoma cells. Int J Cancer. 1970 Sep 15;6(2):172–188. doi: 10.1002/ijc.2910060205. [DOI] [PubMed] [Google Scholar]
  14. Hellström I., Hellström K. E., Sjögren H. O., Warner G. A. Demonstration of cell-mediated immunity to human neoplasms of various histological types. Int J Cancer. 1971 Jan 15;7(1):1–16. doi: 10.1002/ijc.2910070102. [DOI] [PubMed] [Google Scholar]
  15. Hellström K. E., Hellström I. Immunological enhancement as studied by cell culture techniques. Annu Rev Microbiol. 1970;24:373–398. doi: 10.1146/annurev.mi.24.100170.002105. [DOI] [PubMed] [Google Scholar]
  16. Horwitz D. A. Impaired delayed hypersensitivity in systemic lupus erythematosus. Arthritis Rheum. 1972 Jul-Aug;15(4):353–359. doi: 10.1002/art.1780150406. [DOI] [PubMed] [Google Scholar]
  17. Horwitz D. A., Stastny P., Ziff M. Circulating deoxyribonucleic acid--synthesizing mononuclear leukocytes. I. Increased numbers of proliferating mononuclear leukocytes in inflammatory disease. J Lab Clin Med. 1970 Sep;76(3):391–402. [PubMed] [Google Scholar]
  18. Horwitz D. A. The development of macrophages from large mononuclear cells in the blood of patients with inflammatory disease. J Clin Invest. 1972 Apr;51(4):760–768. doi: 10.1172/JCI106870. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Hsu C. C., LoGerfo P. Correlation between serum alpha-globulin and plasma inhibitory effect on PHA-stimulated lymphocytes in colon cancer patients. Proc Soc Exp Biol Med. 1972 Feb;139(2):575–578. doi: 10.3181/00379727-139-36189. [DOI] [PubMed] [Google Scholar]
  20. Hughes L. E., Mackay W. D. Suppression of the tuberculin response in malignant disease. Br Med J. 1965 Dec 4;2(5474):1346–1348. doi: 10.1136/bmj.2.5474.1346. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Kaliss N. Dynamics of immunologic enhancement. Transplant Proc. 1970 Mar;2(1):59–67. [PubMed] [Google Scholar]
  22. LEVIN A. G., MCDONOUGH E. F., Jr, MILLER D. G., SOUTHAM C. M. DELAYED HYPERSENSITIVITY RESPONSE TO DNFB IN SICK AND HEALTHY PERSONS. Ann N Y Acad Sci. 1964 Nov 30;120:400–409. doi: 10.1111/j.1749-6632.1964.tb34739.x. [DOI] [PubMed] [Google Scholar]
  23. Levy N. L., Mahaley M. S., Jr, Day E. D. In vitro demonstration of cell-mediated immunity to human brain tumors. Cancer Res. 1972 Mar;32(3):477–482. [PubMed] [Google Scholar]
  24. Oppenheim J. J., Leventhal B. G., Hersh E. M. The transformation of column-purified lymphocytes with nonspecific and specific antigenic stimuli. J Immunol. 1968 Aug;101(2):262–267. [PubMed] [Google Scholar]
  25. SNELL G. D., CLOUDMAN A. M., WOODWORTH E. Tumor immunity in mice, induced with lyophilized tissue, as influenced by tumor strain, host strain, source of tissue, and dosage. Cancer Res. 1948 Sep;8(9):429–437. [PubMed] [Google Scholar]
  26. Sample W. F., Gertner H. R., Jr, Chretien P. B. Inhibition of phytohemagglutinin-induced in vitro lymphocyte transformation by serum from patients with carcinoma. J Natl Cancer Inst. 1971 Jun;46(6):1291–1297. [PubMed] [Google Scholar]
  27. Silk M. Effect of plasma from patients with carcinoma on in vitro lymphocyte transformation. Cancer. 1967 Dec;20(12):2088–2089. doi: 10.1002/1097-0142(196712)20:12<2088::aid-cncr2820201205>3.0.co;2-1. [DOI] [PubMed] [Google Scholar]
  28. Sjögren H. O., Hellström I., Bansal S. C., Hellström K. E. Suggestive evidence that the "blocking antibodies" of tumor-bearing individuals may be antigen--antibody complexes. Proc Natl Acad Sci U S A. 1971 Jun;68(6):1372–1375. doi: 10.1073/pnas.68.6.1372. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Solowey A. C., Rapaport F. T. Immunologic responses in cancer patients. Surg Gynecol Obstet. 1965 Oct;121(4):756–760. [PubMed] [Google Scholar]
  30. Stjernswärd J., Almgård L. E., Franzén S., von Schreeb T., Wadström L. B. Tumour-distinctive cellular immunity to renal carcinoma. Clin Exp Immunol. 1970 Jun;6(6):963–968. [PMC free article] [PubMed] [Google Scholar]
  31. Takasugi M., Hildemann W. H. Regulation of immunity toward allogeneic tumors in mice. I. Effect of antiserum fractions on tumor growth. J Natl Cancer Inst. 1969 Oct;43(4):843–856. [PubMed] [Google Scholar]
  32. Whittaker M. G., Rees K., Clark C. G. Reduced lymphocyte transformation in breast cancer. Lancet. 1971 May 1;1(7705):892–893. doi: 10.1016/s0140-6736(71)92448-2. [DOI] [PubMed] [Google Scholar]
  33. Yunis E. J., Plate J. M., Ward F. E., Seigler H. F., Amos D. B. Anomalous MLR responsiveness among siblings. Transplant Proc. 1971 Mar;3(1):118–120. [PubMed] [Google Scholar]

Articles from The Journal of Experimental Medicine are provided here courtesy of The Rockefeller University Press

RESOURCES